CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
about
Mechanism of immune evasion in breast cancer.Oncolytic herpes simplex virus interactions with the host immune system.Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer.Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy.Shared ancestry of herpes simplex virus 1 strain Patton with recent clinical isolates from Asia and with strain KOS63.Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus.
P2860
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
@en
type
label
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
@en
prefLabel
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
@en
P2093
P2860
P1433
P1476
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
@en
P2093
Aldo Pourchet
Karsten A Pilones
Matthew Mulvey
Steven R Fuhrmann
P2860
P356
10.1016/J.EBIOM.2016.01.022
P577
2016-01-19T00:00:00Z